New Mexico Proposed Medical Psilocybin Rules
The state has released draft regulations for its medical psilocybin program following approval in 2025.
Updated on Oct. 4, 2026 in Mental Health
Live Poll
Should states prioritize medical program accessibility over strict safety regulations?
The New Mexico Department of Health has proposed new regulations for its state-sanctioned medical psilocybin program. These rules establish standards for patient registration, provider certification, training protocols, and designated treatment locations.
Why it matters
While the program aims to provide treatment for post-traumatic stress disorder, anxiety, and depression, advocates are concerned that the current requirements may restrict access for veterans and rural residents.
New Mexico is the third state to approve a medical psilocybin program, following similar legislative actions in Oregon and Colorado. The current proposal encompasses guidelines for provider certification and patient eligibility.
The players
New Mexico Department of Health
This state agency is responsible for overseeing public health initiatives and is currently drafting regulations for the new medical psilocybin program.
The details
The Department of Health is currently reviewing feedback regarding the proposed framework for psilocybin-assisted therapy. Officials plan to consider all submitted public testimony before moving forward with the final implementation of the state program.
Timeline
The medical psilocybin program was officially approved by the state in 2025.
The department heard public comments on the proposed rules on October 4, 2026.
Health Landscape
New Mexico is following the regulatory pattern established by the Oregon medical psilocybin program. The state's effort to integrate these therapies into clinical practice reflects a growing trend in state-level mental health policy.
The proposed regulations will determine who is eligible to receive psilocybin-assisted treatment for conditions like PTSD and depression. Patients should monitor these rules for updates on access requirements, training standards, and the availability of certified treatment sites.
The takeaway
The development of these regulations marks a significant step in institutionalizing psilocybin-assisted therapy for serious mental health conditions. Future applicants and patients should engage with public hearing opportunities to ensure that accessibility barriers are addressed.
Further reading
Learn more about the evolving treatment landscape in New Mexico Mental Health.
Source note: This article includes information reported by KOAT 7.
Live Poll
Should states prioritize medical program accessibility over strict safety regulations?
